Zhejiang Tailin Bioengineering Co Ltd - Asset Resilience Ratio
Zhejiang Tailin Bioengineering Co Ltd (300813) has an Asset Resilience Ratio of 8.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Tailin Bioengineering Co Ltd (300813) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Zhejiang Tailin Bioengineering Co Ltd assets under control.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Tailin Bioengineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Zhejiang Tailin Bioengineering Co Ltd for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥80.10 Million | 8.46% |
| Total Liquid Assets | CN¥80.10 Million | 8.46% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Tailin Bioengineering Co Ltd maintains only 8.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Tailin Bioengineering Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Tailin Bioengineering Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Zhejiang Tailin Bioengineering Co Ltd (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Tailin Bioengineering Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 19.13% | CN¥183.51 Million ≈ $26.85 Million |
CN¥959.34 Million ≈ $140.38 Million |
+16.07pp |
| 2021-12-31 | 3.06% | CN¥20.05 Million ≈ $2.93 Million |
CN¥655.87 Million ≈ $95.97 Million |
-- |
About Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technolog… Read more